| Active substance | |
|---|---|
| Water Retention | Reduces water retention secondary to decreased estrogen levels |
| Hepatotoxicity | Low potential for liver toxicity, but liver function tests are recommended during prolonged use |
| Lab Test | |
| Also known as | |
| Blood pressure | Can sometimes lower blood pressure due to reduced estrogen levels |
| Trade name | |
| Storage conditions | |
| Chemical name | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropiononitrile) |
| Formula | |
| Substance class | |
| Main action | Inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens |
| Half-life | |
| Dosage (medical) | |
| Dosage (sports) | Not commonly prescribed for sports uses, but dosages in unofficial contexts can vary |
| Effects | Reduces estrogen levels, useful in the treatment of estrogen receptor-positive breast cancer |
| Side effects | Hot flashes, joint symptoms, weakness, mood changes, bone loss, increased risk of osteoporosis |
| Use in sports | |
| Manufacturer | |
| Packing |
Related products
Anastrozole
Anastrozole
Anastrozole
Anastrozole
Anastrozole
Anastrozole
Anastrozole
Anastrozole